The Catalyst

Most Recent Posts


Clinical trials are a critical part of the development of innovative medicines that deliver life-saving benefits to patients.


As one of the founders of a global clinical research organization (CRO) and as current Chair of ACRO, the trade association for CROs, I can assure you that the pharmaceutical, biotechnology and CRO industries are dedicated to the protection, safety, priv


Many times, we have written in this space about clinical trials of new medicines and how they are beneficial not only to patients, but also the economy and the advancement of science and patient care.


Thanksgiving Day. It is a special holiday for millions of families across the U.S. to gather and eat bountiful food and watch endless hours of football (and for me, the Macy's Day parade).

11.20.12 | By Kaelan Hollon

Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting during the 2013 Medicare Part D Open Enrollment Period (Oct. 12 - Dec. 7).

11.19.12 | By Kaelan Hollon

CNN aired an important special called 'Deadly Dose' on prescription drug abuse last night, in which PhRMA's CEO John Castellani was briefly interviewed by Dr. Sanjay Gupta.

11.19.12 | By Preet Bilinski

Diabetes affects so many people in so many ways. PhRMA joined participants from around the area for a recent Step Out: Walk to Stop Diabetes event.

11.16.12 | By Amiee Adasczik

I was honored to represent PhRMA at Rotary International's PolioPlus National Immunization Day (NID) in India last week.

11.15.12 | By Kaelan Hollon

One of the most important aspects living with diabetes is adherence. When a diabetic fails to take care of themselves, an otherwise manageable disease can quickly turn into a hospital admission, or worse. As part of Diabetes Awareness Month and our focus on keeping people healthy, we have a guest blog post from policy analyst Nick McNeill from NEHI, a national health policy institute. He breaks down a new NEHI report about the link between adherence and hospital readmission rates.

11.15.12 | By Rick Smith

Once again, it's time for Medicare open enrollment, when beneficiaries select their Medicare coverage for the coming year.

11.15.12 | By Preet Bilinski

We continue to focus on diabetes [visit the Medicines in Development for Diabetes resource center] with a guest post from Novo Nordisk's Ken Inchausti.

11.14.12 | By Preet Bilinski

For those unfamiliar with diabetes it can be thought of as a minor hindrance rather than a life-changing disease. However, diabetes is a chronic, life-threatening illness that effects Americans across the country.

11.13.12 | By Kaelan Hollon

Being on top of anyone's list of the 'World's Most Innovative Companies' is a mighty fine set of bragging rights, and Apple can put another feather in its hat thanks to

11.08.12 | By Preet Bilinski

Today we have guest post from co-founder and CEO of the Diabetes Daily blog, Elizabeth Zabell Edelman. Elizabeth is a diabetes advocate who was diagnosed in 2005, she talks about the the daily fears, frustrations and triumphs of living with diabetes.